You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status

Article metrics

Article menu

Download PDFPDF

XML
Case Report
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status

 

Online download statistics by month:

Online download statistics by month: January 2020 to August 2025

AbstractFullPdf
Jan 2020440
Feb 202031310
Mar 202015150
Apr 2020232335
May 202032328
Jun 2020171710
Jul 2020232310
Aug 2020535310
Sep 2020343417
Oct 2020242417
Nov 2020272712
Dec 2020343426
Jan 202120207
Feb 2021424216
Mar 2021555514
Apr 2021525210
May 202145456
Jun 202142426
Jul 202128288
Aug 2021161614
Sep 2021202018
Oct 2021262633
Nov 2021141422
Dec 2021262811
Jan 202231337
Feb 202219218
Mar 2022273016
Apr 2022303119
May 2022303019
Jun 2022272710
Jul 202235357
Aug 2022595917
Sep 2022565618
Oct 2022444612
Nov 202241426
Dec 2022565618
Jan 2023535419
Feb 2023838419
Mar 2023585816
Apr 202330309
May 2023394011
Jun 202340404
Jul 2023343413
Aug 2023626214
Sep 202335353
Oct 202339397
Nov 202329299
Dec 202315152
Jan 2024151511
Feb 2024303112
Mar 2024515136
Apr 2024333318
May 202434354
Jun 2024333214
Jul 202450517
Aug 202427267
Sep 2024383915
Oct 2024202020
Nov 2024313213
Dec 2024303212
Jan 2025242413
Feb 202566667
Mar 2025232312
Apr 202536367
May 2025272717
Jun 2025202015
Jul 2025110
Aug 2025110
Total22652286833